Article Details
Retrieved on: 2024-12-03 23:35:17
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Namilumab is an anti-GM-CSF monoclonal antibody formulated to be administered once-monthly as a subcutaneous injection being investigated for the ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here